Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Charcot-Marie-Tooth Disease Type 1F”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableLooking for participantsNCT06339190
What this trial is testing

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Who this might be right for
Neurodegenerative DiseasesDementia
Monash University 1,000
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06592014
What this trial is testing

Lithium for Parkinson's: an Extension Trial

Who this might be right for
Parkinson Disease
State University of New York at Buffalo 35
Not applicableStudy completedNCT07184073
What this trial is testing

Cognitive Fraility and Biomarkers in Older Patients

Who this might be right for
Cognitive ImpairmentFrail Older AdultsOrthopaedic Surgery
Baskent University 129
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,011
Not applicableUnknownNCT05187260
What this trial is testing

Antisense Oligonucleotide for Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
First Affiliated Hospital of Fujian Medical University 1,000
Not applicableLooking for participantsNCT03981003
What this trial is testing

Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 1,150
Testing effectiveness (Phase 2)Study completedNCT03560739
What this trial is testing

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 284
Not applicableStudy completedNCT05821816
What this trial is testing

Effect of Transcranial Direct Current Stimulation (tDCS) on Post-stroke Patients on Neuromotor Recovery

Who this might be right for
Stroke
I.R.C.C.S. Fondazione Santa Lucia 50
Not applicableLooking for participantsNCT07044804
What this trial is testing

Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.

Who this might be right for
Down Syndrome
Floriana Costanzo 36
Post-approval studies (Phase 4)Looking for participantsNCT06733922
What this trial is testing

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 224
Not applicableLooking for participantsNCT05885724
What this trial is testing

Novel Targetable BIOmarkers in ANorexia NervosA

Who this might be right for
Anorexia NervosaAnorexia Nervosa Restricting Type
University Hospital, Basel, Switzerland 32
Not applicableWithdrawnNCT06711510
What this trial is testing

Predict to Prevent PGRN Disease

Who this might be right for
Frontotemporal Dementia (FTD)GRN Related Frontotemporal Dementia
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT05173818
What this trial is testing

Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms

Who this might be right for
Persistent Post-concussive SyndromeConcussion Post Syndrome
Essentia Health 20
Not applicableStudy completedNCT05793437
What this trial is testing

Effects of Permissive Hypercapnia on Concentration of Postoperative Plasma Neurofilament Light

Who this might be right for
Hypercapnia
Affiliated Hospital of Jiaxing University 84
Large-scale testing (Phase 3)Active Not RecruitingNCT05147220
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,001
Not applicableStudy completedNCT04478591
What this trial is testing

The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Amsterdam UMC, location VUmc 117
Not applicableStudy completedNCT05399602
What this trial is testing

The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus

Who this might be right for
HydrocephalusBrain DamageGeneral Anesthetics Toxicity
University Hospital Hradec Kralove 41
Not applicableLooking for participantsNCT05885295
What this trial is testing

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

Who this might be right for
StrokeStroke (CVA) or TIADementia, Vascular+3 more
Imperial College London 700
Not applicableActive Not RecruitingNCT05464355
What this trial is testing

Biomarkers Associated With Postoperative Cognitive Dysfunction

Who this might be right for
DeliriumPostoperative Cognitive DysfunctionCognitive Decline+1 more
University of Oxford 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04695080
What this trial is testing

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Who this might be right for
Advanced Multiple SclerosisProgressive Multiple Sclerosis
Queen Mary University of London 204
Load More Results